• An environmental/lifestyle dementia risk index is broadly associated with cognitive performance • An Alzheimer's genetic risk score is associated with dementia severity and episodic memory • The environmental risk index is more strongly associated with dementia severity than genetic risk Abstract Introduction: We investigated the association of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and an AD genetic risk score (GRS) with cognitive performance.
Introduction
Given both the projected increase in the prevalence of Alzheimer's disease (AD) and other dementias and the lack of disease-modifying treatments for AD, risk reduction strategies focusing on prevention to reduce dementia prevalence are required [1, 2] . Risk assessment tools are a key component of dementia prevention, as they can provide clear and effective communication of key risk factors that can inform personalized prevention regimes to guide the implementation of risk reduction strategies. As AD has a long preclinical phase, risk assessment tools that can identify at-risk individuals in the early stages of the pathological processes may have significant utility in prevention. As some cognitive decline in normal populations may signal increased risk of dementia, it is important to evaluate and compare the sensitivity of AD risk assessment tools for detecting early dementia-related cognitive disturbance.
Cognitive performance is a combination of an individual's inherent cognitive ability, decline promoted by the gradual accumulation of neuropathology associated with various chronic conditions of aging [3, 4] and cognitive reserve promoting resilience to the pathological changes associated with neurodegeneration [5] . Individual differences in cognitive level and trajectories of cognitive performance with aging are substantial [6] .
Nevertheless, performance across multiple tests of cognitive abilities has been observed to be positively inter-correlated. This observation gave rise to the concept of a general factor of cognitive ability ('g') representing the shared variance across observed performance on cognitive tasks [7] . Additionally, cognitive tasks that draw on more similar processes tend to be more highly correlated with each other, which can be accounted for by developing additional factors that define specific cognitive domains [8] . A recently proposed extension of 'g' for the early detection of dementia is a model that distinguishes dementia-related variance in cognitive task performance (δ) from variance that is unrelated to dementia processes (g') [9, 10] . Both g' and δ are derived from a theory-driven confirmatory factor analysis in a structural equation model framework that combines cognitive and functional measures. Functional status is typically measured by activities of daily living (ADL) that represent capacities that are required for autonomous function within society and at home [11] . Given that deficits in cognition and functional status are key characteristics for a clinical diagnosis of dementia, 'δ' has been proposed as a measure to detect early cognitive change and concomitant functional decline [9] . For example, δ is related to dementia status (AUC = 0.942) [10] , dementia severity (r = 0.84) [10] , post-mortem AD neuropathology [12] , abnormal CSF amyloid-β/Tau biomarkers ratios (AUC = 0.78) [13] , cognitive decline and future dementia severity [9, 14, 15] , conversion from MCI to AD (AUC = 0.84) [13] , and conversion from normal cognition to MCI or AD (OR = 1.52) [16] .
There has been increasing interest in evaluating the effect of AD risk factors with preclinical cognitive performance. For example, genetic risk scores (GRS) composed of the top hits from genome-wide association studies of AD have been associated with faster decline in episodic memory [17, 18] and processing speed [18] . Modifiable lifestyle, medical, and environmental risk factors appear to moderate genetic risk of AD and may also have direct effects on vascular cognitive impairment and brain ageing. It has been estimated that 28.2% -48.4% of dementia cases can be attributed to up to nine modifiable risk factors; specifically, including education, midlife hypertension, midlife obesity, hearing loss, late-life depression, diabetes, physical inactivity, smoking, and social isolation [19] [20] [21] . The commonality between these dementia risk factors and those for cognitive decline suggest that risk assessment tools for dementia should also be associated with cognitive decline and cognitive deficits during the preclinical stages [22] . The Cardiovascular Risk Factors, Aging and Dementia (CAIDE) risk score was the first published risk assessment tool for estimating dementia risk and includes midlife measures of vascular risk [23] , with higher scores also been associated with faster rates of cognitive decline [23, 24] . However, CAIDE was developed for use in midlife cohorts and it is possible the weights developed for CAIDE are study specific [24] .
The Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) is a self-report questionnaire-based risk assessment tool composed of 11 risk and 4 protective factors that were identified using an evidence-based medicine approach [25] . The ANU-ADRI has been validated in three independent cohorts and compared to the CAIDE risk score, where it was found to be predictive of incident AD and all cause dementia [24] .
Additionally, the ANU-ADRI was associated with an increased risk of progressing from normal cognition to mild cognitive impairment (MCI) [26] and was found to predict lower brain volumes in the default mode network [27] . However, to date, the association of the ANU-ADRI with cognitive performance has not been evaluated.
The aim of the present study was to expand on this body of research by evaluating the association of the ANU-ADRI in conjunction with an AD GRS with cross-sectional cognitive performance. Cognitive performance was assessed using a comprehensive cognitive test battery in a large community-based cohort of 1,061 older adults without dementia. Three models of cognition were constructed using confirmatory factor analysis (CFA) representing: 1) general cognitive ability (g); 2) dementia-related variance in cognitive task performance (δ) from variance that is unrelated to dementia processes (g'); and 3) cognitive domains for verbal ability, episodic memory, executive function and processing speed.
Methods

Participants
Participants in this study are from the Personality and Total Health (PATH) Through Life Project, which has been described in detail elsewhere [28] . Briefly, participants were randomly sampled from the electoral rolls of the city of Canberra and the neighbouring town of Queanbeyan, Australia, and were recruited into one of three cohorts based on age at baseline, with follow up occurring at 4-year intervals for a total of 12 years. The focus of the present study is on data collected at Wave 4 in the 60+ cohort (age 60-64 at baseline), as this 
ANU-ADRI
The development of the ANU-ADRI and the methodology underlying its computation have been described previously [25] . Briefly, the ANU-ADRI can be computed based on up to 15 domains, with the present score was comprised of 11 domains including age, sex, alcohol consumption, diabetes, education, depression, traumatic brain injury, smoking, social engagement, cognitive activities and dietary fish intake (see Supplementary Materials). For each domain, points weighted by each risk factors effect size are allocated based on varying levels within the domain and overall composite score computed as the sum of all available sub-scores. Three domains were not included in this analysis, namely BMI and hypercholesterolemia (as increased risk of dementia is associated with midlife rather than late-life) and pesticide exposure as data was not available in PATH. However, the ANU-ADRI is still predictive of dementia and MCI even when a subset of variables is used indicating that the variables used in the construction of the ANU-ADRI for this study is sufficient [24, 26] . The ANU-ADRI total score was transformed into a Z-score.
Genotyping
The top-hit late-onset Alzheimer's disease (LOAD) single nucleotide polymorphisms (SNPs) identified via genome wide association studies [29] [30] [31] [32] [33] [34] from 23 loci (Supplementary Table 1 ) were genotyped as previously described [18] . The two SNPs defining the APOE alleles were genotyped separately using Taqman assays previously described [35] . A weighted explained variance genetic risk score (EV-GRS) for LOAD was constructed. The EV-GRS is the sum of all the LOAD risk alleles across the individuals, weighted by the minor allele frequency (MAF) and the odds ratio associated with LOAD. The formula for calculating the EV-GRS is described in the Supplementary Materials. The EV-GRS was transformed into a z-score.
Activities of daily living
Informants (n = 1438) nominated by PATH participants were asked to rate participants on deficits in the performance of everyday activities using the Bayer Activities of Daily Living (B-ADL) [36] in a telephone interview. B-ADL is comprised of 25 items, with the first two evaluating participants' ability to manage everyday activities and taking care of themselves. Items three to twenty assess specific tasks of everyday life, while the remaining five relate to cognitive functions important for performing activities of daily living.
Informants were asked to rate participants on a scale of 1 (never) to 10 (always), with an option of not applicable. Individual item scores were summed, with the total divided by the number of items rated with a score, providing a final score of between 1 and 10. The B-ADL was reverse coded so that higher scores indicated better function and transformed into a ZScore.
Cognitive test battery
The PATH cognitive test battery included measures used at previous waves as well as additional tests that were added to the battery to enable clinical diagnoses according to DSM5 criteria [37] . The test battery assessed four cognitive domains. More detailed descriptions of the individual tests can be found in the Supplementary Materials.
Episodic Memory was assessed using the Immediate and Delayed Recall of the first trial of the California Verbal Learning Test (IR and DR) [38] and the Benton Visual
Retention Test (BVRT) Administration B [39] .
Verbal Ability/Fluency was assessed using the Spot-the-Word test [40] , Boston Naming Test (BNT) [41] and the Controlled Oral Word Association Test (COWAT) [42] .
Perceptual Speed was assessed using the Symbol Digit Modalities test (SDMT) [43] , the Trail Making Test part A (TMT-A) [42] and Simple and Choice Reaction Time (SRT & CRT) [44] .
Executive Function was assessed using the Victoria Stroop Test interference score [45] , the Zoo Map test from the Behavioural Assessment of the Dysexecutive Syndrome Test Battery [46] , the Trail Making Test Part B (TMT-B) [42] , and Digit Span Backwards (DSB) from the Wechsler Memory Scale [47] , with participants were scored based on the number of correct trials (DSB total score) and the longest sequence repeated backwards (DSB Sequence length).
The means and standard deviations for the raw cognitive tests are presented in Table   1 . TMT-A, TMT-B, Stroop, SRT and CRT scores were reversed coded so that a higher score also indicates better performance. For TMT-A, TMT-B and Stroop Interference, the Skew was >± 3 or Kurtosis was >± 10, as such extreme outliers (99% percentile on TMT-A; 99.8% percentile on TMT-B and Stroop) were winsorized so that the cognitive test performance distribution approached normality to facilitate estimation of the CFA models [48] . Cognitive test scores were transformed into Z-scores.
Statistical Analysis
All statistical analyses were performed using R version 3.4.2 software [49] . All missing values for the cognitive tests, B-ADL and the ANU-ADRI (see Table 1 ) were imputed using a Random Forest algorithm from the 'missForrest' R package [50] .
Confirmatory factor analysis (CFA) can be used to represent the correlations between a number of observed variables (indicators) in terms of a smaller number of unobserved latent variables (factors). CFA is a hypothesis driven approach in which the loading of an indicator onto a factor is based on a priori evidence and theory. CFA models were estimated using mean-adjusted weighted least squares (WLSM) in the 'lavaan' R package [49, 51] .
Three separate CFA models were constructed (Figure 1 ). First, Model 1 ( Figure 1a) is a single factor model in which all the individual cognitive tests loaded onto a single latent factor representing general cognitive ability (g) was constructed. Second, Model 2 ( Figure   1b ), presents bifactor model distinguishing dementia-related variance in cognitive task performance (δ) from variance that is unrelated to dementia processes (g') was constructed.
Individual cognitive tests were loaded onto both g' and δ, while the B-ADL loaded only onto [52] . A CFI > 0.9, RMSEA and SRMSR < 0.08 were considered good estimates of model fit.
Under a structural equation modelling framework, the ANU-ADRI and the EV-GRS were introduced as exogenous indicator variables into Models 1-3 to examine direct effect of the ANU-ADRI and the EV-GRS on latent cognitive factors.
Results
Distributions for the ANU-ADRI, EV-GRS, B-ADL and the individual cognitive test scores are described in Table 1 . The frequencies of the individual sub-indices of the ANU-ADRI are presented in Table 2 .
Model 1: 'g'
Fit statistics and standardised parameter estimates for the single-factor 'g' CFA model are presented in Table 3 and were acceptable, indicating that the overall fit of Model 1 provided support for the hypothesized structure of the cognitive tests. All the factor loadings, except for SRT and Zoo Map, were above 0.30, ranging in absolute value from 0.33 -0.64 and thus accounting for between 10.9 -40.9% of the variance in general cognitive ability.
The ANU-ADRI was significantly associated with general cognitive ability.
Specifically, a one SD increase in the ANU-ADRI (5.86 points) corresponded to a decrease of -0.40 (95% CI: -0.37 --0.43) in 'g' and accounted for 16.2% of variance (Table 4; Supplementary Table 2 ). The association between the EV-GRS and 'g' was non-significant (Table 4; Supplementary Table 2) .
Model 2: g' and δ
Standardised parameter estimates, and model fit indices for Model 2 are presented in Table 3 -0.332 --0.059) ( Table 4; Supplementary Table 2) . A one SD increase in the ANU-ADRI was associated with worse performance in both δ and g'.
However, a larger decrease in variance explained (16.3%) was observed for δ as compared with to g' (3.2%). For the EV-GRS, a significant association was observed for δ (β = -0.08; 95% CI = -0.166 --0.003), which explained 0.58% of the variation in δ.
Model 3: Cognitive Domains
Fit statistics and standardised parameter estimates for the four-factor cognitive domain model are provided in Table 3 . All the model fit indices were acceptable, indicating that the overall fit of the CFA model provided support for the hypothesized cognitive domain structure. The standardized factor loadings confirmed that each of the cognitive domains were well defined by the individual cognitive tests and were all above 0.30, ranging in absolute value from 0.31 -0.81 and thus accounting for between 9.6 -65% of the variance. 
Discussion
This study's main finding was that the ANU-ADRI was cross-sectionally broadly associated with cognitive performance. A higher score was significantly associated with worse performance in 'g', representing a latent variable of general cognitive ability. When we further partitioned g into two independent factors, g' and δ, the ANU-ADRI was associated with worse factor scores for both indicators. Given that deficits in cognition and functional status are key characteristics for a clinical diagnosis of dementia, the latent dementia construct ' δ' was conceptualised as a measure to detect early cognitive change and concomitant functional decline associated with neurodegenerative disease [9] . In contrast, g' reflects cognitive task performance that is unrelated to functional decline caused by neurodegenerative disease [9] . Accordingly, we observed that the effect size of the ANU-ADRI -δ association was larger in comparison to the ANU-ADRI -g' association. This suggests that while the ANU-ADRI is broadly negatively correlated with cognitive performance, it is more specifically associated with dementia-related processes.
Differences in cognitive ability across domains reflect neuroanatomical differences in localized regional structures/networks and the connectivity of those networks. As such, the differential association of risk and protective factors with specific cognitive domains may reflect associations with particular neuroanatomical structures. The ANU-ADRI was associated with worse performance across all four cognitive domains, however larger effects were observed for processing speed and executive function. Similarly, the CAIDE risk score is broadly associated with poorer cognitive function, with larger deficits in executive functioning and processing speed, in comparison to memory [53] . Deficits in processing speed and executive functioning are characteristic of vascular dementia (VaD) caused by cerebrovascular disease such as infarcts, lacunas, hippocampal sclerosis and white matter lesions [54, 55] . Supporting the link between CAIDE and cerebrovascular pathology, a higher baseline score was associated with more severe deep white mater lesions, lower grey matter and hippocampal volume, but not with amyloid accumulation, 20 -30 years later [53] . This suggests that the ANU-ADRI may also be particularly sensitive to changes in cognitive performance resulting from cerebrovascular disease. The ANU-ADRI has been previously observed to be associated with lower brain volumes in cortical grey matter and the default mode network [27] , but associations with cerebrovascular pathology are yet to be evaluated.
In conjunction with the ANU-ADRI, we evaluated the association of an AD GRS with cognitive performance. The GRS, in comparison to the ANU-ADRI, was not significantly associated with general cognitive ability factor in Model 1. In Model 2, a higher EV-GRS was significantly associated only with worse performance in δ. Notably, the EV-GRS effect size (0.58%) was substantially smaller than the ANU-ADRI effect size (16.3%).
To our knowledge this is the first study to examine the association of an AD GRS with δ, though APOE ε4 has previously been associated with δ [12] . The association of AD genetic markers with δ and not g' suggests that these risk loci may not promote neural damage independently of AD pathogenesis. As such, these results provide additional support for the validity of δ as a latent dementia phenotype representing dementia severity. In Model 3, a higher EV-GRS was only associated with worse episodic memory performance. Impairment in episodic memory is usually the earliest and most salient characteristic of AD, with deficits in other cognitive domains observed with increasing AD severity [56] . Overall, that the EV-GRS was selectively associated with preclinical memory performance -and that the effect sizes were generally small -likely reflects the fact that the genes comprising the EV-GRS were identified for their associations to AD and its underlying neuropathology.
This study has a number of strengths including a large sample size, a comprehensive cognitive test battery allowing for the modelling of latent cognitive factors, a narrow age range cohort, and the ability to compare an AD environmental/lifestyle risk score to an AD genetic risk score. The main limitation of the current study is its cross-sectional design which has limited ability to evaluate causal relationships and are potentially subject to greater confounding due to cohort effects in comparison to prospective studies. As such, further validation of the ANU-ADRI with cognitive decline is required. Additionally, while PATH was recruited as a representative sample, the educational attainment of the cohort is above the national average and it is a predominantly Caucasian sample, potentially limiting the generalizability of the results of this study.
In conclusion, a higher ANU-ADRI score is associated with worse performance in dementia-related variance in cognitive task performance in comparison to variance in cognitive function unrelated to dementia processes. Additionally, more specific associations were observed with perceptual speed, executive function, episodic memory and verbal ability. In contrast, an AD GRS was specifically associated with dementia-related variance in cognitive task performance and episodic memory. These results provide additional support for using the ANU-ADRI across the cognitive spectrum in individual patient assessment to inform intervention and treatment strategies aimed at delaying dementia.
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